Tobacco News and Research

RSS

Potential new COPD drug

A study led by researchers at Boston University School of Medicine (BUSM) has shown that a compound used in some skin creams may halt the progression of emphysema and reverse some of the damage caused by the disease. When the compound Gly-His-Lys (GHK) was applied to lung cells from patients with emphysema, normal gene activity in altered cells was restored and damaged aspects of cellular function were repaired.

1 Sep 2012

Astellas Pharma receives FDA approval for Xtandi to treat metastatic CRPC

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.

1 Sep 2012

Water pipe smoking affects lung function and respiratory symptoms as cigarette smoking

A new study published in the journal Respirology reveals that water pipe smoking, such as hookah or bong smoking, affects lung function and respiratory symptoms as much as cigarette smoking.

1 Sep 2012

Roundup: Flurry of health bills as Calif. legislature winds down; Kansas City health data exchange opens up

The window to save the Healthy Families program is narrowing to a small slit, with just a single day left to pass bills. ... Today -- until midnight tonight -- is the last day for legislation to be passed this year. The governor has until the end of September to veto or approve bills.

1 Sep 2012

Global tobacco use remains high

Results from the Global Adult Tobacco Survey suggest that almost 50% of men worldwide consume tobacco in one form or another.

31 Aug 2012

Renal artery stent revascularization reduces blood pressure in patients with severe hypertension

Patients with uncontrolled renovascular hypertension saw a significant improvement in their blood pressure with renal artery stent deployment. The multicenter HERCULES trial, evaluating the safety and effectiveness of the RX Herculink Elite Stent, found that patients with higher blood pressure levels at baseline had the most dramatic reduction in blood pressure following intervention.

31 Aug 2012

Ironwood receives FDA approval for Linzess to treat chronic idiopathic constipation, IBS

The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C) in adults.

31 Aug 2012

Sosei’s QVA149 Phase III study on COPD meets primary endpoint

Sosei Group Corporation confirms the information released today by Novartis that results from the fifth QVA149 (indacaterol maleate / glycopyrronium bromide) Phase III study, SPARK, met its primary endpoint of a reduced rate of moderate-to-severe COPD exacerbations compared to glycopyrronium bromide.

31 Aug 2012

George Washington University SPHHS launches Childhood Asthma Leadership Coalition

Today the George Washington University School of Public Health and Health Services (SPHHS) announced the launch of the Childhood Asthma Leadership Coalition, a multi-sector group of advocates and experts dedicated to raising awareness and advancing public policies to improve the health of children who suffer from asthma.

30 Aug 2012

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

30 Aug 2012

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma.

30 Aug 2012

Viewpoints: Adding a middle man to Medicare; Circumcision wars; Who is an extremist on abortion?

Bear in mind that health expenses will still have to be mainly paid for by some kind of insurance; that's in the nature of medical care, with its high but unpredictable cost. So what we're doing here is replacing government insurance with a program that gives people money to buy private insurance - that is, adding an extra layer of middlemen.

29 Aug 2012

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at ERS Annual Congress

Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.

28 Aug 2012

Heart healthy lifestyle could avoid up to 400 cardiac events and 200 deaths in Swedish PCI patients

Up to 400 cardiac events and 200 deaths in Swedish PCI patients could be avoided by following a heart healthy lifestyle, according to research from the SPICI study presented at ESC Congress 2012. The results were presented at ESC press conference by Professor Joep Perk from Linnaeus University and at the scientific session by Dr Roland CARLSSON.

28 Aug 2012

FDA approves Gilead’s Stribild to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

Expanding anti-smoking legislation could reduce occurrence of STEMIs

Many European countries have passed anti-smoking legislation which bans smoking from restaurants, bars and public buildings. After implementation of such a smoking ban on 1 January 2008 in the metropolitan area of Bremen in northwest Germany (800,000 inhabitants) a 16% decline in ST-elevation myocardial infarction (STEMI) was observed. STEMI is the severest form of myocardial infarction.

26 Aug 2012

Electronic cigarettes far less harmful and may be beneficial to health

Smoking is the most preventable risk factor for cardiac and lung disease and is expected to cause 1 billion deaths during the 21st century. Electronic cigarettes have been marketed in recent years as a safer habit for smokers, with several millions of people already using them worldwide.

26 Aug 2012

Study addresses important early risk factors of cardiovascular health in adolescents

Early exposure to tobacco smoke is associated with various adverse health outcomes in children and adolescents, including low birth weight and impaired lung growth and function.

26 Aug 2012

GlcNAc plays a key role in keeping cancerous monsters ‘fed’

Behaving something like ravenous monsters, tumors need plentiful supplies of cellular building blocks such as amino acids and nucleotides in order to keep growing at a rapid pace and survive under harsh conditions. How such tumors meet these burgeoning demands has not been fully understood.

24 Aug 2012

Tobacco News and Research

Potential new COPD drug

Astellas Pharma receives FDA approval for Xtandi to treat metastatic CRPC

Water pipe smoking affects lung function and respiratory symptoms as cigarette smoking

Roundup: Flurry of health bills as Calif. legislature winds down; Kansas City health data exchange opens up

Global tobacco use remains high

Renal artery stent revascularization reduces blood pressure in patients with severe hypertension

Ironwood receives FDA approval for Linzess to treat chronic idiopathic constipation, IBS

Sosei’s QVA149 Phase III study on COPD meets primary endpoint

George Washington University SPHHS launches Childhood Asthma Leadership Coalition

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

Viewpoints: Adding a middle man to Medicare; Circumcision wars; Who is an extremist on abortion?

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at ERS Annual Congress

Heart healthy lifestyle could avoid up to 400 cardiac events and 200 deaths in Swedish PCI patients

FDA approves Gilead’s Stribild to treat HIV-1 infection

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Expanding anti-smoking legislation could reduce occurrence of STEMIs

Electronic cigarettes far less harmful and may be beneficial to health

Study addresses important early risk factors of cardiovascular health in adolescents

GlcNAc plays a key role in keeping cancerous monsters ‘fed’

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News